Oscient Pharmaceuticals promoted Mark Glickman to SVP, sales and marketing and corporate officer. Glickman was VP sales and is credited with the growth of the company's lead product, Antara capsules.
Nektar Therapeutics announced the appointment of Randall Moreadith, MD, PhD, to SVP, drug development and chief development officer. Moreadith will report to Nektar's president and CEO, Howard W. Robin.
SUPPLIERS AND VENDORS
Management consulting firm Campbell Alliance announced the appointment of Nader Naeymi-Rad as COO. Naeymi-Rad was formerly a SVP and head of the firm's brand management practice. Darius Naigamwalla has assumed that position.